Owlet Baby Care

Owlet is the pioneer of smart baby monitoring, having monitored more than 1 million babies. Owlet now announces BabySatTM, the first FDA-cleared pulse oximeter featuring the Owlet wire-free sock, designed for in-home use.  In June 2023, the FDA cleared this device for use in measuring and displaying SpO2 and Pulse Rate, for spot checking and/or continuous monitoring of well-perfused patients 1-18 months old and 6 to 30 pounds in the home environment.   Owlet has combined a form-factor that is a parent-loved design used on over 1 million babies in a consumer setting, combined with hospital-grade accuracy to transform care at home.  

There is a need to revolutionize home-based pulse oximetry.  At-home monitoring has provided physicians with critical data that their patient’s condition is stable and has provided an ability to monitor progress and improvement over time. However, these benefits come at the cost of introducing many medical devices into the home that may be cumbersome, inaccurate, or provide alarms that are overly-sensitive.  These devices can result in heightened stress and anxiety in caregivers and lack of adherence with in-home pulse oximetry monitoring.

BabySat offers:  ACCURACY IN A INFANT-CENTRIC & PARENT-FRIENDLY DESIGN, via:
-Proven accuracy of SpO2 and Pulse Rate vital sign readings
-Clinically proven accuracy across all skin tones
-Comparable readings to existing FDA cleared pulse oximeters through varying degrees of motion
-Due to the BabySat adhesive-free design, the risk of skin irritation is minimal when used according to instructions for use
-More informed virtual care via App-based vital sign data trends for caregivers 

To Order, contact https://adapthealth.com/owlet/ or visit our website at owletcare.com.
Please contact health@owletcare.com with additional inquiries.